private:cytoo
|
328097
|
Jun 12th, 2022 12:00AM
|
CYTOO
|
2.4K
|
30.00
|
Open
|
Biotechnology
|
Jun 11th, 2022 11:40PM
|
Jun 11th, 2022 11:40PM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Dec 3rd, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Dec 3rd, 2020 09:47AM
|
Dec 3rd, 2020 09:47AM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Dec 2nd, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Dec 2nd, 2020 12:08PM
|
Dec 2nd, 2020 12:08PM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Dec 1st, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Dec 1st, 2020 10:42AM
|
Dec 1st, 2020 10:42AM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Nov 30th, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Nov 30th, 2020 12:46PM
|
Nov 30th, 2020 12:46PM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Nov 29th, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Nov 29th, 2020 05:45PM
|
Nov 29th, 2020 05:45PM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Nov 28th, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Nov 28th, 2020 01:38PM
|
Nov 28th, 2020 01:38PM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Nov 27th, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Nov 27th, 2020 09:59AM
|
Nov 27th, 2020 09:59AM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Nov 26th, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Nov 26th, 2020 10:59AM
|
Nov 26th, 2020 10:59AM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|
private:cytoo
|
328097
|
Nov 25th, 2020 12:00AM
|
CYTOO
|
1.6K
|
20.00
|
Open
|
Biotechnology
|
Nov 25th, 2020 01:56PM
|
Nov 25th, 2020 01:56PM
|
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
|
Open
|
High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, muscle health
|
Open
|
7 parvis Louis Néél, BHT B52, BP50
|
Grenoble
|
|
FR
|
38040
|
|
Cytoo
|
|
Pharmaceuticals & Biotechnology
|